Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma
2017 · New England Journal of Medicine · 402 citations
https://doi.org/10.1056/nejmoa1701769
C
Caroline Dartigeas
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
123
Papers
3.7K
Citations
26
h-index
45
i10-index
Caroline Dartigeas is an academic researcher from Université de Tours. The author has contributed to research in topics: Chronic Lymphocytic Leukemia Research & Lymphoma Diagnosis and Treatment & Immunodeficiency and Autoimmune Disorders. The author has an h-index of 26, co-authored 105 publications.
Papers by this author
worksDasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients
2021 · British Journal of Haematology · 42 citations
https://doi.org/10.1111/bjh.17654
Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis
2023 · Nature Communications · 34 citations
https://doi.org/10.1038/s41467-022-34642-6
New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies
2015 · Experimental Hematology and Oncology · 23 citations
https://doi.org/10.1186/s40164-016-0036-3
Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE study
2024 · Annals of Hematology · 6 citations
https://doi.org/10.1007/s00277-024-05666-3
A retrospective analysis of 450 TP53 mutations in a real life cohort of CLL from the French Innovative Leukemia Organization (FILO) group
2017 · HAL (Le Centre pour la Communication Scientifique Directe) · 2 citations
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat